Literature DB >> 7390331

Studies on amyotrophic lateral sclerosis by neutron activation analysis--2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases.

F Yoshimasu, M Yasui, Y Yase, S Iwata, D C Gajdusek, C J Gibbs, K M Chen.   

Abstract

Metal analysis of calcium, manganese, aluminum and copper in CNS tissue samples of degenerative CNS disease cases (six Japanese ALS, three Japanese Alzheimer disease, four Guam PD, one Guam ALS) using neutron activation analysis, was conducted with following results: Five of six Japanese ALS cases, two of three Japanese Alzheimer disease cases and all of four Guam PD cases showed a high content of calcium and aluminum in CNS tissue with a significant positive correlation between calcium and aluminum and/or between calcium and manganese. These findings suggest a possible process of metal-induced soft tissue calcification with interaction of other di- and/or trivalent cations such as aluminum, manganese in CNS tissue of these degenerative CNS diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390331     DOI: 10.1111/j.1440-1819.1980.tb01515.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


  13 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway.

Authors:  T P Flaten
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

3.  Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 4.  Motor neuron disease: etiology, pathogenesis and treatment--a review.

Authors:  D J Donohoe; B Brady
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

5.  Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

Authors:  Matthew Schrag; Claudius Mueller; Udochukwu Oyoyo; Mark A Smith; Wolff M Kirsch
Journal:  Prog Neurobiol       Date:  2011-05-11       Impact factor: 11.685

Review 6.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

7.  Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys.

Authors:  R M Garruto; S K Shankar; R Yanagihara; A M Salazar; H L Amyx; D C Gajdusek
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.

Authors:  Herman L Lelie; Amir Liba; Megan W Bourassa; Madhuri Chattopadhyay; Pik K Chan; Edith B Gralla; Lisa M Miller; David R Borchelt; Joan Selverstone Valentine; Julian P Whitelegge
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

Review 9.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

Review 10.  Is the Aluminum Hypothesis dead?

Authors:  Theodore I Lidsky
Journal:  J Occup Environ Med       Date:  2014-05       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.